Exhibit 99.1
Mar 3, 2015
Presbia Announces the Appointment of Robert J. Cresci to the Board
DUBLIN—(BUSINESS WIRE)—Presbia PLC (NASDAQ: LENS), an ophthalmic device company that has developed and is currently marketing the Presbia Flexivue Microlens™, a proprietary optical lens implant for treating presbyopia, announced today that it has appointed Robert J. Cresci to serve on its Board of Directors. Mr. Cresci has been a Managing Director of Pecks Management Partners Ltd., an investment management firm, since 1990.
“Mr. Cresci brings extensive expertise related to growth companies from his experience with Pecks Management Partners, and serving on other public and private company boards of directors. He will also provide Presbia with significant knowledge regarding accounting issues and public company matters,” said Todd Cooper, President and CEO of Presbia.
Mr. Cresci’s biography can be found on our website at www.presbia.com.
Forward-Looking Statements
Information provided and statements contained in this press release that are not purely historical are forward-looking statements. Such forward-looking statements only speak as of the date of this press release and Presbia assumes no obligation to update the information included in this press release. Statements made in this press release that are forward-looking in nature may involve risks and uncertainties. Accordingly, readers are cautioned that any such forward-looking statements are not guarantees and are subject to certain risks, uncertainties and assumptions that are difficult to predict. Although Presbia believes that the expectations reflected in such forward-looking statements are reasonable as of the date made, expectations may prove to have been materially different from the results expressed or implied by such forward-looking statements. Unless otherwise required by law, Presbia also disclaims any obligation to update its view of any such risks or uncertainties or to announce publicly the result of any revisions to the forward-looking statements made in this press release.
About Presbia
Presbia PLC (NASDAQ:LENS) is an ophthalmic device company that has developed and is currently marketing the presbyopia-correcting Presbia Flexivue Microlens™, a miniature lens that is implanted in a corneal pocket created by a femtosecond laser. The Presbia Flexivue Microlens™ has received a CE mark for the European Economic Area, allowing the lens to be marketed in over 30 countries across Europe. A staged pivotal U.S. clinical trial for the Presbia Flexivue Microlens™ commenced in 2014.
Presbia PLC
Monica Yamada, 323-860-4903
monica@presbia.com
Source: Presbia PLC
News Provided by Acquire Media